Wiki source code of to-do-list
Last modified by manuelmenendez on 2025/02/08 17:21
Show last authors
| author | version | line-number | content |
|---|---|---|---|
| 1 | This document outlines the full workflow for Neurodiagnoses—from data acquisition and AI model training to clinical validation, ethical compliance, cloud deployment, and future expansion into CNS Digital Twins. | ||
| 2 | |||
| 3 | ---- | ||
| 4 | |||
| 5 | == 1. Data Management & Integration == | ||
| 6 | |||
| 7 | * ((( | ||
| 8 | **Data Acquisition & Storage:** | ||
| 9 | |||
| 10 | * Download raw data from external sources (e.g., ADNI, GP2, PPMI, Enroll-HD, UK Biobank, etc.). | ||
| 11 | * Upload and organize datasets in EBRAINS Buckets and in the /datasets/ directory on GitHub. | ||
| 12 | ))) | ||
| 13 | * ((( | ||
| 14 | **Data Conversion & Format:** | ||
| 15 | |||
| 16 | * Convert all datasets to standardized formats (.csv, .json, .h5) to facilitate AI processing. | ||
| 17 | ))) | ||
| 18 | * ((( | ||
| 19 | **Data Harmonization:** | ||
| 20 | |||
| 21 | * Implement automated data ingestion scripts to streamline updates from new sources. | ||
| 22 | * Set up data harmonization methods to ensure consistency across different sources (e.g., genetics, neuroimaging, biomarkers, digital health). | ||
| 23 | ))) | ||
| 24 | * ((( | ||
| 25 | **Federated Learning:** | ||
| 26 | |||
| 27 | * Enable federated learning techniques to train AI models on multi-center data without sharing raw patient data (ensuring GDPR compliance). | ||
| 28 | ))) | ||
| 29 | |||
| 30 | ---- | ||
| 31 | |||
| 32 | == 2. AI-Based Risk Prediction & Diagnosis == | ||
| 33 | |||
| 34 | * ((( | ||
| 35 | **Predictive Modeling:** | ||
| 36 | |||
| 37 | * Implement machine learning models (e.g., Random Forest, Neural Networks) for dementia risk stratification. | ||
| 38 | * Develop probabilistic models (e.g., KNN Imputer, Bayesian approaches) to handle missing data. | ||
| 39 | ))) | ||
| 40 | * ((( | ||
| 41 | **Training with Multi-Modal Data:** | ||
| 42 | |||
| 43 | * Train AI models using data from biomarkers, EEG, MRI, and lifestyle factors. | ||
| 44 | * Store pre-trained models in the /models/ directory for future use. | ||
| 45 | ))) | ||
| 46 | * ((( | ||
| 47 | **Diagnostic Annotation System:** | ||
| 48 | |||
| 49 | * Implement real-time AI-based diagnostic annotation that produces two types of reports for each case: | ||
| 50 | ** **Probabilistic Diagnosis:** Traditional diagnosis with associated probability percentages. | ||
| 51 | ** **Tridimensional Diagnosis:** A structured classification based on three axes—etiology, molecular markers, and neuroanatomoclinical correlations. | ||
| 52 | * Integrate Explainable AI techniques (e.g., SHAP) to ensure transparency in predictions. | ||
| 53 | * Explore advanced deep learning methods for pattern recognition in neuroimaging data. | ||
| 54 | * Investigate the use of Large Language Models (LLMs) for summarizing and generating medical reports. | ||
| 55 | ))) | ||
| 56 | |||
| 57 | ---- | ||
| 58 | |||
| 59 | == 3. EEG, Neuroimaging & Sleep Analysis == | ||
| 60 | |||
| 61 | * ((( | ||
| 62 | **EEG/MEG Analysis:** | ||
| 63 | |||
| 64 | * Process EEG/MEG data using tools like MNE-Python. | ||
| 65 | * Apply spectral analysis and connectivity metrics to derive EEG biomarkers for dementia detection. | ||
| 66 | ))) | ||
| 67 | * ((( | ||
| 68 | **Sleep Monitoring:** | ||
| 69 | |||
| 70 | * Integrate sleep data from wearables (smartwatches, headbands) as early biomarkers. | ||
| 71 | ))) | ||
| 72 | * ((( | ||
| 73 | **Neuroimaging Analysis:** | ||
| 74 | |||
| 75 | * Utilize MRI volumetric analysis to assess brain atrophy in high-risk patients. | ||
| 76 | * Implement functional MRI (fMRI) analysis to correlate neuroanatomical changes with cognitive function. | ||
| 77 | ))) | ||
| 78 | |||
| 79 | ---- | ||
| 80 | |||
| 81 | == 4. Clinical Validation & Pilot Testing == | ||
| 82 | |||
| 83 | * ((( | ||
| 84 | **Pilot Study Design:** | ||
| 85 | |||
| 86 | * Design a multicenter pilot study to validate AI-generated diagnostic scores. | ||
| 87 | * Recruit a clinical validation cohort from European research hospitals. | ||
| 88 | ))) | ||
| 89 | * ((( | ||
| 90 | **Performance Evaluation:** | ||
| 91 | |||
| 92 | * Compare AI-based diagnoses with traditional clinician diagnoses. | ||
| 93 | * Develop and track validation metrics (e.g., AUROC, precision-recall, false positive rates). | ||
| 94 | ))) | ||
| 95 | * ((( | ||
| 96 | **Feedback and Refinement:** | ||
| 97 | |||
| 98 | * Implement clinician feedback loops to refine the AI model based on real-world usage. | ||
| 99 | * Publish validation results in peer-reviewed journals to enhance credibility. | ||
| 100 | ))) | ||
| 101 | |||
| 102 | ---- | ||
| 103 | |||
| 104 | == 5. Ethical, Regulatory & GDPR Compliance == | ||
| 105 | |||
| 106 | * ((( | ||
| 107 | **Regulatory Compliance:** | ||
| 108 | |||
| 109 | * Ensure all AI models comply with relevant regulations (e.g., EU AI Act, GDPR). | ||
| 110 | ))) | ||
| 111 | * ((( | ||
| 112 | **Privacy Preservation:** | ||
| 113 | |||
| 114 | * Implement privacy-preserving techniques (Federated Learning, Differential Privacy) to protect patient data. | ||
| 115 | * Develop data anonymization pipelines prior to AI processing. | ||
| 116 | ))) | ||
| 117 | * ((( | ||
| 118 | **Consent & Data Governance:** | ||
| 119 | |||
| 120 | * Establish consent management systems for patient data contributions. | ||
| 121 | * Ensure interoperability with hospital Electronic Health Record (EHR) systems. | ||
| 122 | ))) | ||
| 123 | |||
| 124 | ---- | ||
| 125 | |||
| 126 | == 6. EBRAINS Deployment & Cloud Infrastructure == | ||
| 127 | |||
| 128 | * **Cloud Deployment:** | ||
| 129 | ** Deploy AI models on the EBRAINS Cloud for real-time inference. | ||
| 130 | * **Collaborative Development:** | ||
| 131 | ** Set up Jupyter Notebooks in EBRAINS Lab for collaborative development and testing. | ||
| 132 | ** Automate model training pipelines using GitHub Actions or EBRAINS HPC resources. | ||
| 133 | * **Optimization:** | ||
| 134 | ** Optimize computational efficiency to enable real-time processing of clinical data. | ||
| 135 | |||
| 136 | ---- | ||
| 137 | |||
| 138 | == 7. Interactive Web Application for Clinicians & Researchers == | ||
| 139 | |||
| 140 | * **Web App Development:** | ||
| 141 | ** Develop an interactive web-based diagnostic tool using frameworks such as Flask, FastAPI, or Streamlit. | ||
| 142 | ** Allow clinicians to input biomarker data and receive real-time AI predictions. | ||
| 143 | * **Report Generation:** | ||
| 144 | ** Enable the generation of PDF reports for clinical decision support. | ||
| 145 | * **Custom Dashboards:** | ||
| 146 | ** Integrate dashboards that display risk stratification results. | ||
| 147 | * **Deployment:** | ||
| 148 | ** Deploy the web app on neurodiagnoses.com using hosting services like Netlify, Vercel, or AWS. | ||
| 149 | |||
| 150 | ---- | ||
| 151 | |||
| 152 | == 8. Cross-Project Collaborations == | ||
| 153 | |||
| 154 | * ((( | ||
| 155 | **External Partnerships:** | ||
| 156 | |||
| 157 | * Collaborate with projects such as AI-Mind for EEG-based predictive modeling. | ||
| 158 | * Work with LETHE for lifestyle-based cognitive decline risk scoring. | ||
| 159 | * Leverage PROMINENT’s multi-modal AI pipeline to refine dementia subtype classification. | ||
| 160 | * Expand partnerships with clinical institutions to enhance dataset diversity. | ||
| 161 | ))) | ||
| 162 | * ((( | ||
| 163 | **Open-Source Community:** | ||
| 164 | |||
| 165 | * Encourage contributions via GitHub (code improvements, new features) and EBRAINS discussion pages (research and validation). | ||
| 166 | ))) | ||
| 167 | |||
| 168 | ---- | ||
| 169 | |||
| 170 | == 9. Long-Term Expansion & Future Goals == | ||
| 171 | |||
| 172 | * **Disease Progression Modeling:** | ||
| 173 | ** Explore AI-powered models for tracking neurodegeneration over time. | ||
| 174 | * **CNS Digital Twins:** | ||
| 175 | ** Develop CNS Digital Twins by integrating multi-omics data, neuroimaging, and digital health records to create personalized simulations of disease progression. | ||
| 176 | * **Continuous Monitoring:** | ||
| 177 | ** Investigate the integration of wearable health tracking devices for ongoing cognitive assessment. | ||
| 178 | * **Open-Access API:** | ||
| 179 | ** Create an API to allow global research collaborations with access to AI diagnostic tools. | ||
| 180 | * **Sustainability & Updates:** | ||
| 181 | ** Regularly update the system with new data and algorithm improvements. | ||
| 182 | ** Establish long-term funding and partnership strategies to ensure sustainability. | ||
| 183 | |||
| 184 | ---- | ||
| 185 | |||
| 186 | === Key Resources === | ||
| 187 | |||
| 188 | * **GitHub Repository:** [[Neurodiagnoses on GitHub>>https://github.com/Fundacion-de-Neurociencias/neurodiagnoses/discussions]] | ||
| 189 | * **EBRAINS Collaboratory:** [[Neurodiagnoses on EBRAINS>>url:https://wiki.ebrains.eu/bin/view/Collabs/neurodiagnoses/]] |
- 1. Data Management & Integration
- 2. AI-Based Risk Prediction & Diagnosis
- 3. EEG, Neuroimaging & Sleep Analysis
- 4. Clinical Validation & Pilot Testing
- 5. Ethical, Regulatory & GDPR Compliance
- 6. EBRAINS Deployment & Cloud Infrastructure
- 7. Interactive Web Application for Clinicians & Researchers
- 8. Cross-Project Collaborations
- 9. Long-Term Expansion & Future Goals